VCYT
VCYT
NASDAQ · Biotechnology

Veracyte Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$53.63
+2.34 (+4.56%)
As of Jun 21, 9:59 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 15 83%
Hold 2 11%
Sell 1 6%
Price Target
Analyst Price Target -12.6% upside
Low Target $30.44
Average Target $46.85
High Target $57.64
Current Price $53.63
Current
$53.63
Target
$46.85
$30.44 $46.85 avg $57.64
Scenario Analysis
Bear Case
$30.44
-43.2%
Low target
Base Case
$46.85
-12.6%
Avg target
Bull Case
$57.64
+7.5%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$53.81
-0.3% from high
52-Week Low
$22.61
+137.2% from low
50-Day SMA
$40.85
+31.3% vs SMA
200-Day SMA
$34.09
+57.3% vs SMA
RSI (14)
37.6
Neutral
Target vs 52W High
$46.85
-12.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%